Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress.
Ontology highlight
ABSTRACT: Retinoic acid (RA) in association with chemotherapy or with arsenic trioxide (ATO) results in high cure rates of acute promyelocytic leukemia (APL). We show that RA-induced differentiation of human leukemic cell lines and primary blasts dramatically increases their sensitivity to endoplasmic reticulum (ER) stress-inducing drugs at doses that are not toxic in the absence of RA. In addition, we demonstrate that the PERK pathway, triggered in response to ER stress, has a major protective role. Moreover, low amounts of pharmacologically induced ER stress are sufficient to strongly increase ATO toxicity. Indeed, in the presence of ER stress, ATO efficiently induced apoptosis in RA-sensitive and RA-resistant APL cell lines, at doses ineffective in the absence of ER stress. Our findings identify
SUBMITTER: Masciarelli S
PROVIDER: S-EPMC5808088 | biostudies-literature | 2018 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA